Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:32:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:47:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1 on a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T15:23:50.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous detailed study content with a minimal error page that includes a Home link and a revision notice.
    Difference
    18%
    Check dated 2026-09-20T19:29:25.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, reflecting an update to the site’s rendering framework.
    Difference
    0.1%
    Check dated 2026-08-30T21:57:38.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the prior v3.6.4 as part of a maintenance build. This update changes the release identifier without altering study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-09T08:15:30.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.